Drug Shortage Report for BIVALIRUDIN INJECTION
Report ID | 171467 |
Drug Identification Number | 02505517 |
Brand name | BIVALIRUDIN INJECTION |
Common or Proper name | Bivalirudin infection |
Company Name | AVIR PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | BIVALIRUDIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | vials |
ATC code | B01AE |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-10-11 |
Actual start date | 2022-10-11 |
Estimated end date | 2023-02-24 |
Actual end date | 2023-02-24 |
Shortage status | Resolved |
Updated date | 2023-02-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOULEVARD INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-02-27 | French | Compare |
v12 | 2023-02-27 | English | Compare |
v11 | 2023-02-17 | French | Compare |
v10 | 2023-02-17 | English | Compare |
v9 | 2023-02-03 | French | Compare |
v8 | 2023-02-03 | English | Compare |
v7 | 2023-01-03 | French | Compare |
v6 | 2023-01-03 | English | Compare |
v5 | 2022-11-17 | French | Compare |
v4 | 2022-11-17 | English | Compare |
v3 | 2022-10-12 | English | Compare |
v2 | 2022-10-11 | French | Compare |
v1 | 2022-10-11 | English | Compare |
Showing 1 to 13 of 13